3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Other
1
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
27
Pheochromocytoma
11
Pituitary Neoplasms
10
Carcinoma, Neuroendocrine
10
Thyroid Neoplasms
8
Sarcoma
8
Thyroid Cancer, Papillary
7
Paraganglioma
7
Neuroblastoma
6
Adrenocortical Carcinoma
6
Ovarian Neoplasms
5
Small Cell Lung Carcinoma
4
Parathyroid Neoplasms
4
Pancreatic Neoplasms
4
Osteosarcoma
4
Neoplasms
4
Melanoma
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Medullary
4
Carcinoma, Hepatocellular
4
Adrenal Gland Neoplasms
4
Thyroid Carcinoma, Anaplastic
3
Stomach Neoplasms
3
Pituitary ACTH Hypersecretion
3
Head and Neck Neoplasms
3
Cushing Syndrome
3
Colorectal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Diseases
×
Endocrine
×
30 days
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled